These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27628784)

  • 1. Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application.
    Balzus B; Colombo M; Sahle FF; Zoubari G; Staufenbiel S; Bodmeier R
    Int J Pharm; 2016 Nov; 513(1-2):247-254. PubMed ID: 27628784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium.
    Balzus B; Sahle FF; Hönzke S; Gerecke C; Schumacher F; Hedtrich S; Kleuser B; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jun; 115():122-130. PubMed ID: 28189623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers.
    Döge N; Hönzke S; Schumacher F; Balzus B; Colombo M; Hadam S; Rancan F; Blume-Peytavi U; Schäfer-Korting M; Schindler A; Rühl E; Skov PS; Church MK; Hedtrich S; Kleuser B; Bodmeier R; Vogt A
    J Control Release; 2016 Nov; 242():25-34. PubMed ID: 27394682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General method for the quantification of drug loading and release kinetics of nanocarriers.
    Schwarzl R; Du F; Haag R; Netz RR
    Eur J Pharm Biopharm; 2017 Jul; 116():131-137. PubMed ID: 28017797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and comparative in vitro evaluation of various dexamethasone-loaded pH-sensitive polymeric nanoparticles intended for dermal applications.
    Sahle FF; Gerecke C; Kleuser B; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):21-31. PubMed ID: 27845215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
    Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
    Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
    Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the drug release from nanoparticles: Overcoming the shortcomings of dialysis by using novel optical techniques and a mathematical model.
    Xie L; Beyer S; Vogel V; Wacker MG; Mäntele W
    Int J Pharm; 2015 Jul; 488(1-2):108-19. PubMed ID: 25847513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin-Assisted Method Allows Assessment of Release of Hydrophobic Drugs From Nanocarriers.
    Gil D; Frank-Kamenetskii A; Barry J; Reukov V; Xiang Y; Das A; Varma AK; Kindy MS; Banik NL; Vertegel A
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28881095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release from semisolid dosage forms: a comparison of two testing methods.
    Petró É; Paál TL; Erős I; Kenneth AS; Baki G; Csóka I
    Pharm Dev Technol; 2015 May; 20(3):330-6. PubMed ID: 24328512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
    Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
    Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting drug release kinetics from nanocarriers inside dialysis bags.
    Yu M; Yuan W; Li D; Schwendeman A; Schwendeman SP
    J Control Release; 2019 Dec; 315():23-30. PubMed ID: 31629038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New doxorubicin nanoparticles engineered from calcium-crosslinked carbomer and a microemulsion precursor.
    Sintov AC; Enden G
    Drug Dev Ind Pharm; 2017 May; 43(5):830-838. PubMed ID: 27648681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-multishell nanocarriers: Transport and release of dexamethasone probed by soft X-ray spectromicroscopy.
    Yamamoto K; Klossek A; Flesch R; Ohigashi T; Fleige E; Rancan F; Frombach J; Vogt A; Blume-Peytavi U; Schrade P; Bachmann S; Haag R; Hedtrich S; Schäfer-Korting M; Kosugi N; Rühl E
    J Control Release; 2016 Nov; 242():64-70. PubMed ID: 27568290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.
    Behzadi S; Serpooshan V; Sakhtianchi R; Müller B; Landfester K; Crespy D; Mahmoudi M
    Colloids Surf B Biointerfaces; 2014 Nov; 123():143-9. PubMed ID: 25262409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.
    Castelli F; Messina C; Sarpietro MG; Pignatello R; Puglisi G
    AAPS PharmSciTech; 2002; 3(2):E9. PubMed ID: 12916946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review.
    Sheshala R; Anuar NK; Abu Samah NH; Wong TW
    AAPS PharmSciTech; 2019 Apr; 20(5):164. PubMed ID: 30993407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.
    de Andrade DF; Zuglianello C; Pohlmann AR; Guterres SS; Beck RC
    AAPS PharmSciTech; 2015 Dec; 16(6):1409-17. PubMed ID: 25986595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.